Laboratory Medicine ›› 2024, Vol. 39 ›› Issue (3): 298-301.DOI: 10.3969/j.issn.1673-8640.2024.03.016
Previous Articles Next Articles
Received:
2022-08-19
Revised:
2024-04-13
Online:
2024-03-30
Published:
2024-04-24
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2024.03.016
日期 | 白细胞计数/(×109/L-1) | 中性粒细胞 计数/(×109/L-1) | 中性粒细胞百分比/ % | 淋巴细胞 计数/(×109/L-1) | 淋巴细胞百分比/ % | 红细胞 计数/(×1012/L-1) | 血细胞比容/% | 血红蛋白/(g·L-1) | 血小板 计数/(×109/L-1) |
---|---|---|---|---|---|---|---|---|---|
第1天 | 2.84↓ | 1.94 | 68.20 | 0.80↓ | 28.20 | 4.13 | 45.80↑ | 157.00↑ | 160.00 |
第2天 | 7.88 | 5.79 | 73.50 | 1.39 | 17.60↓ | 3.69↓ | 39.90 | 139.00 | 124.00↓ |
第4天 | 13.20↑ | 7.78↑ | 58.90 | 3.15 | 23.90 | 3.78↓ | 40.00 | 141.00 | 53.00↓ |
第5天 | 18.79↑ | 8.78↑ | 46.80 | 6.17↑ | 32.80 | 3.87 | 41.40 | 145.00 | 64.00↓ |
第9天 | 16.04↑ | 6.68↑ | 41.70 | 7.08↑ | 44.10 | 3.65↓ | 38.40 | 133.00 | 209.00 |
第14天 | 11.94↑ | 3.80 | 31.90↓ | 6.28↑ | 52.6↑ | 3.49↓ | 36.90 | 125.00 | 203.00 |
第20天 | 12.68↑ | 3.58 | 28.30↓ | 6.76↑ | 53.3↑ | 3.01↓ | 30.40↓ | 105.00↓ | 326.00 |
第25天 | 12.04↑ | 4.40 | 36.60↓ | 5.58↑ | 46.30 | 2.79↓ | 28.40↓ | 98.00↓ | 358.00↑ |
第27天 | 13.23↑ | 5.27 | 39.80↓ | 5.82↑ | 44.00 | 4.07 | 36.90 | 132.00 | 301.00 |
日期 | 白细胞计数/(×109/L-1) | 中性粒细胞 计数/(×109/L-1) | 中性粒细胞百分比/ % | 淋巴细胞 计数/(×109/L-1) | 淋巴细胞百分比/ % | 红细胞 计数/(×1012/L-1) | 血细胞比容/% | 血红蛋白/(g·L-1) | 血小板 计数/(×109/L-1) |
---|---|---|---|---|---|---|---|---|---|
第1天 | 2.84↓ | 1.94 | 68.20 | 0.80↓ | 28.20 | 4.13 | 45.80↑ | 157.00↑ | 160.00 |
第2天 | 7.88 | 5.79 | 73.50 | 1.39 | 17.60↓ | 3.69↓ | 39.90 | 139.00 | 124.00↓ |
第4天 | 13.20↑ | 7.78↑ | 58.90 | 3.15 | 23.90 | 3.78↓ | 40.00 | 141.00 | 53.00↓ |
第5天 | 18.79↑ | 8.78↑ | 46.80 | 6.17↑ | 32.80 | 3.87 | 41.40 | 145.00 | 64.00↓ |
第9天 | 16.04↑ | 6.68↑ | 41.70 | 7.08↑ | 44.10 | 3.65↓ | 38.40 | 133.00 | 209.00 |
第14天 | 11.94↑ | 3.80 | 31.90↓ | 6.28↑ | 52.6↑ | 3.49↓ | 36.90 | 125.00 | 203.00 |
第20天 | 12.68↑ | 3.58 | 28.30↓ | 6.76↑ | 53.3↑ | 3.01↓ | 30.40↓ | 105.00↓ | 326.00 |
第25天 | 12.04↑ | 4.40 | 36.60↓ | 5.58↑ | 46.30 | 2.79↓ | 28.40↓ | 98.00↓ | 358.00↑ |
第27天 | 13.23↑ | 5.27 | 39.80↓ | 5.82↑ | 44.00 | 4.07 | 36.90 | 132.00 | 301.00 |
日期 | 肝功能指标 | 心肌酶指标 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
丙氨酸氨基转移酶/(U·L-1) | 天门冬氨酸氨基转移酶/(U·L-1) | 总胆红素/(μmol·L-1) | 直接胆红素/(μmol·L-1) | 间接胆红素/(μmol·L-1) | 肌酸激酶/ (U·L-1) | 肌酸激酶MB同工酶/(U·L-1) | ||||
第1天 | 49.80 | 188.50 | 61.50 | 6.30 | 55.20 | 1 374.90 | 2 060.30 | |||
第2天 | 68.70 | 144.40 | 127.60 | 8.90 | 118.70 | 984.80 | 1 508.00 | |||
第4天 | 65.10 | 50.20 | 190.10 | 16.20 | 173.90 | |||||
第9天 | 25.10 | 31.10 | 208.90 | 21.40 | 187.50 | 101.50 | 49.80 | |||
第14天 | 12.00 | 30.30 | 186.90 | 16.80 | 170.10 | |||||
第20天 | 9.40 | 24.60 | 142.70 | 17.10 | 125.60 | |||||
第27天 | 8.40 | 27.00 | 132.4 | 15.40 | 117.00 | |||||
日期 | 心肌酶指标 | 肾功能指标 | 感染指标 | |||||||
乳酸脱氢酶/(U·L-1) | α-羟丁酸脱氢酶/(U·L-1) | 肌酐/(μmol·L-1) | 尿酸/(μmol·L-1) | 尿素/(mmol·L-1) | 二氧化碳结合力/ (mmol·L-1) | C反应蛋白/(mg·L-1) | ||||
第1天 | 1 267.40 | 679.80 | 68.90 | 399.90 | 3.46 | 18.10 | 72.20 | |||
第2天 | 1 619.30 | 909.20 | 99.00 | 460.80 | 7.21 | 18.30 | 81.60 | |||
第4天 | 75.90 | 241.20 | 5.31 | 18.30 | 20.30 | |||||
第9天 | 495.90 | 309.00 | 57.70 | 154.40 | 1.31 | 19.50 | 1.90 | |||
第14天 | 56.90 | 150.00 | 1.33 | 21.60 | 1.00 | |||||
第20天 | 0.18 | |||||||||
第27天 | 54.40 | 224.00 | 1.73 | 19.70 | 0.35 |
日期 | 肝功能指标 | 心肌酶指标 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
丙氨酸氨基转移酶/(U·L-1) | 天门冬氨酸氨基转移酶/(U·L-1) | 总胆红素/(μmol·L-1) | 直接胆红素/(μmol·L-1) | 间接胆红素/(μmol·L-1) | 肌酸激酶/ (U·L-1) | 肌酸激酶MB同工酶/(U·L-1) | ||||
第1天 | 49.80 | 188.50 | 61.50 | 6.30 | 55.20 | 1 374.90 | 2 060.30 | |||
第2天 | 68.70 | 144.40 | 127.60 | 8.90 | 118.70 | 984.80 | 1 508.00 | |||
第4天 | 65.10 | 50.20 | 190.10 | 16.20 | 173.90 | |||||
第9天 | 25.10 | 31.10 | 208.90 | 21.40 | 187.50 | 101.50 | 49.80 | |||
第14天 | 12.00 | 30.30 | 186.90 | 16.80 | 170.10 | |||||
第20天 | 9.40 | 24.60 | 142.70 | 17.10 | 125.60 | |||||
第27天 | 8.40 | 27.00 | 132.4 | 15.40 | 117.00 | |||||
日期 | 心肌酶指标 | 肾功能指标 | 感染指标 | |||||||
乳酸脱氢酶/(U·L-1) | α-羟丁酸脱氢酶/(U·L-1) | 肌酐/(μmol·L-1) | 尿酸/(μmol·L-1) | 尿素/(mmol·L-1) | 二氧化碳结合力/ (mmol·L-1) | C反应蛋白/(mg·L-1) | ||||
第1天 | 1 267.40 | 679.80 | 68.90 | 399.90 | 3.46 | 18.10 | 72.20 | |||
第2天 | 1 619.30 | 909.20 | 99.00 | 460.80 | 7.21 | 18.30 | 81.60 | |||
第4天 | 75.90 | 241.20 | 5.31 | 18.30 | 20.30 | |||||
第9天 | 495.90 | 309.00 | 57.70 | 154.40 | 1.31 | 19.50 | 1.90 | |||
第14天 | 56.90 | 150.00 | 1.33 | 21.60 | 1.00 | |||||
第20天 | 0.18 | |||||||||
第27天 | 54.40 | 224.00 | 1.73 | 19.70 | 0.35 |
[1] |
RADOSHEVICH L, COSSART P. Listeria monocytogenes:towards a complete picture of its physiology and pathogenesis[J]. Nat Rev Microbiol, 2018, 16(1):32-46.
DOI URL |
[2] | ROGALLA D, BOMAR P A. Listeria monocytogenes[J]. StatPearls Publishing, 2022. |
[3] | MATLE I, MBATHA K R, MADOROBA E. A review of Listeria monocytogenes from meat and meat products:epidemiology,virulence factors,antimicrobial resistance and diagnosis[J]. Onderstepoort J Vet Res, 2020, 87(1):e1-e20. |
[4] | VALENTI M, RANGANATHAN N, MOORE L S, et al. Listeria monocytogenes infections:presentation,diagnosis and treatment[J]. Br J Hosp Med(Lond), 2021, 82(10):1-6. |
[5] |
FAN Z, XIE J, LI Y, et al. Listeriosis in mainland China:a systematic review[J]. Int J Infect Dis, 2019, 81:17-24.
DOI URL |
[6] | 蒋钟吉, 许智坤, 吴劲松, 等. 深圳单核细胞增生李斯特菌感染10例临床分析[J]. 中国抗生素杂志, 2022, 47(11):1202-1206. |
[7] | Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria[S]. M45-3rd,CLSI, 2016. |
[8] | PAGLIANO P, ARSLAN F, ASCIONE T. Epidemiology and treatment of the commonest form of listeriosis:meningitis and bacteraemia[J]. Infez Med, 2017, 25(3):210-216. |
[9] |
JANEZ N, SKRLJ B, STERNISA M, et al. The role of the Listeria monocytogenes surfactome in biofilm formation[J]. Microb Biotechnol, 2021, 14(4):1269-1281.
DOI URL |
[10] |
ISEPPI R, STEFANI S, DE NIEDERHAUSERN S, et al. Characterization of anti-Listeria monocytogenes properties of two bacteriocin-producing Enterococcus mundtii isolated from fresh fish and seafood[J]. Curr Microbiol, 2019, 76(9):1010-1019.
DOI |
[11] |
SCALLAN E, HOEKSTRA R M, ANGULO F J, et al. Foodborne illness acquired in the United States-major pathogens[J]. Emerg Infect Dis, 2011, 17(1):7-15.
DOI URL |
[12] | 肖贵勇, 马晓曼, 王佳佳, 等. 一例孕产妇单核细胞增生李斯特菌感染的溯源调查及发病机制探讨[J]. 中国食品卫生杂志, 2022, 34(2):287-291. |
[13] | 张新娇. 妊娠期李斯特菌病2例报告并文献复习[J]. 中国计划生育和妇产科, 2021, 13(8):90-92. |
[14] |
CRAIG A M, DOTTERS-KATZ S, KULLER J A, et al. Listeriosis in pregnancy:a review[J]. Obstet Gynecol Surv, 2019, 74(6):362-368.
DOI URL |
[15] |
HASBUN J, SEPULVEDA-MARTINEZ A, HAYE M T, et al. Chorioamnionitis caused by Listeria monocytogenes:a case report of ultrasound features of fetal infection[J]. Fetal Diagn Ther, 2013, 33(4):268-271.
DOI URL |
[16] |
DISSON O, GRAYO S, HUILLET E, et al. Conjugated action of two species-specific invasion proteins for fetoplacental listeriosis[J]. Nature, 2008, 455(7216):1114-1118.
DOI |
[17] | LECUIT M. Listeria monocytogenes,a model in infection biology[J]. Cell Microbiol, 2020, 22(4):e13186. |
[1] | YU Feng, HU Longhua, XIAO Yanping, YANG Junping. Virulence genes and molecular characteristics of Klebsiella pneumoniae isolated from bloodstream infection patients [J]. Laboratory Medicine, 2024, 39(3): 249-255. |
[2] | . [J]. Laboratory Medicine, 2024, 39(3): 307-310. |
[3] | WANG Yanyan, WANG Junrui, ZHENG Wenqi, LAN Haixia, GUO Sufang. Drug resistance of Bacteroides isolated from clinic and characteristics of Bacteroides fragilis bft genotyping [J]. Laboratory Medicine, 2024, 39(1): 47-52. |
[4] | CHEN Qing, XU Rong, SUN Jingyong. Resistance mechanisms and molecular epidemiology of Pseudomonas aeruginosa from patients with bronchiectasis in Shanghai [J]. Laboratory Medicine, 2023, 38(11): 1020-1025. |
[5] | DENG Chen, DAI Jiaze, QIU Lihong, SHEN Weiting, CAI Mufa, LUO Wenying. Molecular epidemic characteristics of hypervirulent Klebsiella pneumoniae in Zhanjiang [J]. Laboratory Medicine, 2023, 38(11): 1026-1031. |
[6] | . [J]. Laboratory Medicine, 2023, 38(11): 1109-1110. |
[7] | ZHU Yurong, ZHANG Dan, HE Yaxing, LI Jingjing, HUANG Jing, LI Ting, LIU Peng, LIU Ronghua. Classification and epidemiology characteristics of Klebsiella pneumoniae isolated from clinic [J]. Laboratory Medicine, 2023, 38(5): 435-440. |
[8] | . [J]. Laboratory Medicine, 2022, 37(11): 1075-1078. |
[9] | YAN Xisheng, LEI Lei, WANG Jian. Relationship between Helicobacter pylori virulence genotypes and early renal damage in patients with peptic ulcer [J]. Laboratory Medicine, 2022, 37(1): 16-22. |
[10] | . [J]. Laboratory Medicine, 2021, 36(12): 1295-1298. |
[11] | HUANG Yun, LI Congrong. Research progress on hypervirulent Klebsiella pneumonia [J]. Laboratory Medicine, 2021, 36(11): 1181-1185. |
[12] | GUO Wei, HUANG Jianghua, WU Bei, CHEN Fang, HE Xiaohua. Drug resistance and virulence distribution characteristics of clinical isolates of Enterococcus in a hospital [J]. Laboratory Medicine, 2020, 35(12): 1267-1271. |
[13] | HE Lihua, NI Lijun, YANG Simin, YU Xiaoyu, ZHOU Aiping, HU Liang, GUO Jian, WU Wenjuan. Clinical application of RT-PCR for Klebsiella pneumoniae producing KPC carbapenemase [J]. Laboratory Medicine, 2020, 35(10): 983-987. |
[14] | ZHONG Feng, FENG Yi, ZHANG Jingjing, XU Yan, FANG Yongmei, TAO Xiubin, WU Jing. In vitro antimicrobial activity and biofilm inhibitory effect of imipenem combined with tigecycline against mucoid Pseudomonas aeruginosa [J]. Laboratory Medicine, 2020, 35(6): 519-523. |
[15] | CHEN Xiangming, HE Ping, LI Tin, ZHANG Haiqing, HU Yang. In vitro antibacterial activity and mechanism of artesunate on Propionibacterium acnes [J]. Laboratory Medicine, 2020, 35(4): 318-322. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||